Showing results (391-400 of 478) with videos related to
Sort By:
Pageof 48
American Journal of Surgery|November 8, 2018
Prospective validation of the safety of a laparoscopic cholecystectomy training paradigm featuring incremental autonomyTarik D Madni, Evan Barrios, Jonathan B Imran, et al.Journal of Burn Care & Research : Official Publication of the American Burn Association|May 24, 2018
Impact of a Laser Service Line for Burn Scar on a Dedicated Burn OR's Flow and ProductivityTarik D Madni, John E Hoopman, Xingchen Li, et al.Journal of Clinical Child Psychology|September 18, 1997
Investigating family-based alternatives to institution-based mental health services for youth: lessons learned from the pilot study of a randomized field trialS W Henggeler, M D Rowland, S G Pickrel, et al.The Journal of Pediatrics|October 16, 2002
Cutaneous manifestations of hyper-IgE syndrome in infants and childrenSarah L Chamlin, Timothy H McCalmont, Bari B Cunningham, et al.FEMS Microbiology Ecology|September 29, 2018
Impact of hydrologic boundaries on microbial planktonic and biofilm communities in shallow terrestrial subsurface environmentsH J Smith, A J Zelaya, K B De León, et al.Journal of Viral Hepatitis|March 4, 2017
Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p studyE B Cunningham, B Hajarizadeh, N A Bretana, et al.Human Immunology|August 1, 1993
Recognition by HLA-A2-restricted cytotoxic T lymphocytes of endogenously generated and exogenously provided synthetic peptide analogues of the influenza A virus matrix proteinS Y Sauma, M C Gammon, M A Bednarek, et al.Journal of the American College of Cardiology|March 27, 2001
Stenting versus thrombolysis in acute myocardial infarction trial (STAT)M R Le May, M Labinaz, R F Davies, et al.The Canadian Journal of Cardiology|October 21, 1998
Coronary stenting in unstable angina: early and late clinical outcomesM Madan, J F Marquis, M R de May, et al.Health Science Reports|April 10, 2020
Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trialJason Grebely, Phillip Read, Evan B Cunningham, et al.Pageof 48